Skip to main content
Medicine logoLink to Medicine
. 2022 Aug 12;101(32):e29896. doi: 10.1097/MD.0000000000029896

Total shoulder arthroplasty versus reverse total shoulder arthroplasty: Outcome comparison in osteoarthritis patients with or without concurrent rotator cuff deficiency

Haifeng Liu a, Tony Chieh-Ting Huang b, Hanzhong Yu c, Yicun Wang d, Daping Wang a,*, Zeling Long a,*
PMCID: PMC9371544  PMID: 35960077

Abstract

Osteoarthritis (OA) is a common shoulder disorder that impacts shoulder functions. Shoulder arthroplasty is often required to restore function and quality of life. Reverse total shoulder arthroplasty (RSA), which was originally designed mainly for irreparable rotator cuff damage, has gained popularity in recent years for the treatment of advanced shoulder OA instead of the clinically standard total shoulder arthroplasty (TSA). However, this RSA has some nonnegligible flaws such as higher complications rate and economic cost, not mention the following problems caused by irreversible physical structural damage. Therefore, the employment of RSA needs to be carefully considered. This study aimed to compare TSA and RSA in OA patients with or without rotator cuff damage to better guide clinical decision making. We believe the radical use of RSA in patients without rotator cuff deficiency may cause more harm than good.

We queried the Nationwide Inpatient Sample (NIS) database from 2011 to 2014 to collect information on OA patients who received TSA and RSA. Patients were divided into 2 groups of comparison according to the presence of rotator cuff deficiency and matched with propensity score analysis.

A total of 57,156 shoulder arthroplasties were identified. RSA patients in the rotator cuff deficiency group had significant higher transfusion rates and longer hospital stays. RSA patients without rotator cuff deficiency had a statistically significantly higher number of implant-related mechanical complications, acute upper respiratory infections and postoperative pain. Overall, RSA incurred higher costs in both groups.

For OA patients with rotator cuff deficiencies, RSA has its benefits as complication rates were comparable to TSA. For those patients without rotator cuff deficiencies, the use of RSA should be reconsidered as there were more complications with higher severity.

Keywords: arthroplasty, osteoarthritis, reverse total shoulder arthroplasty, rotator cuff, total shoulder arthroplasty

1. Introduction

Osteoarthritis (OA) of the glenohumeral joint often result in painful shoulders.[1,2] In cases when surgical intervention is warranted, joint replacement has been recommended by the American Academy of Orthopedic Surgeons (AAOS) as it has been shown to result in significant improvement of pain, quality of life, function, and overall patient health.[311] Moreover, total shoulder arthroplasty (TSA) has been recommended by AAOS over hemiarthroplasty (HA) due to better outcomes and less chance of revision.[12]

Reverse total shoulder arthroplasty (RSA) was first developed by Grammont in 1980s specifically for the management of irreparable rotator cuff damage, complex fractures as well as a salvage option for previously failed conventional TSA, in which the rotator cuff tendons are deficient.[1316] The congruent joint surfaces of the reverse ball-and-socket design provides inherent stability, due to its altered center of shoulder joint rotation that increases the deltoid moment arm thus enhance the torque produced by deltoid, as a result, it compensates for the deficiency of RC and improve the shoulder elevation in these patients.[13,1719]

Notably, RSA has some disadvantages that limit its wide usage; first of all, the RSA prothesis is much more expensive than the other prothesis.[20] Secondly, RSA has high risk of shoulder dislocation,[21,22] which causes repeated pain and suffering to patients as well as additional healthcare cost for treatment. Moreover, previous studies reported higher surgical complications rates such as mechanical loosening, infection.[23] and hemorrhage[24] in patients who received RSA compared to TSA.

Traditionally, TSA has been the standard treatment for shoulder OA. However, in the recent years, the use of RSA has increased rapidly and became preferred over TSA even when rotator cuff deficiency is not present.[20,25]

The purpose of current study is to investigate the complication rates associated with RSA surgery when used for the treatment of different conditions, and more specifically, the postoperative outcome of OA patients with or without rotator cuff deficiency who were treated with either TSA or RSA, providing further evidence to guide surgical decision for the surgical management of OA.

2. Methods

2.1. Study design and data source

This study is a descriptive study. The clinical information of patients was queried from the Nationwide Inpatient Sample (NIS) from 2011 to 2014, a database released by the Healthcare Cost and Utilization Project. The NIS database contains all-payer data on hospital inpatient stays from States participating in the Healthcare Cost and Utilization Project (HCUP). Each year of the NIS includes over 7 million inpatient stay data. It gathered more than 100 features from each of the discharges, including demographical information, hospital information, comorbidities, diagnoses during the stay, types of procedures, etc. The tremendous size of the NIS data provides significant benefits for the understanding of clinical problems from a statistical perspective.

2.2. Data extraction and processing

Using the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes, we identified patients who underwent primary procedures as TSA (81.80), RSA (81.88), HA (81.81) during the period from 2011 to 2014. There were totally 57,156 samples extracted, 25,554 for TSA, 22,337 for RSA, and 9265 for HA. To further analyze the data, we categorized OA patients into 2 groups based on the presence of rotator cuff deficiencies (Fig. 1). Postoperative complications, length of hospital stay, costs, were recorded. A list of procedure codes used are listed in Supplemental Table 4, http://links.lww.com/MD/H62.

Figure 1.

Figure 1.

The sample selection and matching process.

2.3. Data analysis

In order to compare the differences between the outcomes of TSA and RSA in the patients with or without rotator cuff deficiencies, patients were matched using a propensity score analysis method. The baseline characteristics used for matching included age, gender, race, hospital location, bed-size, ownership of hospital, and twenty-nine comorbidities which have already been measured in the NIS data. Additionally, 7 rotator cuff related diagnoses were added to the group with rotator cuff deficiencies. All the characteristics passed the normality test and were then fit into a logistic regression model to calculate propensity scores which can be used to identify similar patients for each group. Patients in different groups with closest score were matched and each patient could only be match once. Wilcoxon rank-sum tests were used to evaluate differences for numerical variables, while Chi-squared tests were used for categorical variables. A P-value <0.05 was considered statistically significant. All statistical data analyses were performed using SAS 9.4 software and Python.

3. Results

3.1. Patient demographic

A total of 57,156 shoulder arthroplasties were identified in the NIS database (44.7% TSAs, 16.21% HAs, and 39.08% RSAs) from 2011–2014 (Table 1). For TSA, 50.70% and 49.21% of patients were female and male, respectively. The average age of TSA patients was 67.31 ± 9.66 years of age. For HA, 62% and 38% of patients were female and male, respectively. The average age of HA patients was 66.18 ± 13.5 years of age. For RSA, 63.79% and 36.21% of patients were female and male, respectively. The average age of RSA patients was 72.38 ± 8.93 years of age. Other hospital related demographic data was displayed in Supplementary Table 1, http://links.lww.com/MD/H62.

Table 1.

Demographic characteristics of all patients undergo shoulder arthroplasties.

TSA HA RSA Unprofiled P value
Sex
 Female (%) 12,972 (50.79) 5736 (62) 14,244 (63.79) 38 <0.000
 Male (%) 12,566 (49.21) 3516 (38) 8084 (36.21)
Age at surgery
 n 25,546 9260 22,332 18 <0.000
 Mean (SD), yr 67.31 (9.66) 66.18 (13.5) 72.38 (8.93)
Race
 White (%) 21,150 (90.47) 7403 (87.1) 18,171 (89.03) 4869 <0.000
 Black (%) 1003 (4.29) 430 (5.06) 897 (4.39)
 Hispanic (%) 669 (2.86) 399 (4.69) 783 (3.84)
 Asian/Pacific islander (%) 95 (0.41) 56 (0.66) 91 (0.45)
 Native American (%) 78 (0.33) 34 (0.4) 77 (0.38)
 Others (%) 383 (1.64) 177 (2.08) 391 (1.92)
Total (%) 25,554 (44.71) 9265 (16.21) 22,337 (39.08)

3.2. Primary diagnoses

A list of diagnoses for each procedure is presented in Table 2 as defined by ICD-9-CM (International Classification of Disease, Ninth Revision, Clinical Modification). Five most common diagnoses were listed: osteoarthrosis, arthropathy, aseptic necrosis, rotator cuff injuries, humeral fractures. Osteoarthritis was the most common diagnosis for all 3 procedures (90.55%, 39.47%, 45.20% for TSA, HA, RSA, respectively) with a total of 26,893 counts (64.55%).

Table 2.

Primary diagnosis for patients with different shoulder arthroplasties.

Diagnosis TSAn(%) HAn(%) RSAn(%) Overall
Osteoarthritis 23,140 (90.55) 3657 (39.47) 10,096 (45.2) 36,893 (64.55)
Arthropathy 1044 (4.09) 341 (3.68) 3166 (14.17) 4551 (7.96)
Aseptic necrosis 424 (1.66) 616 (6.65) 168 (0.75) 1208 (2.11)
Rotator cuff injury 131 (0.51) 212 (2.29) 4235 (18.96) 4578 (8.01)
Humeral fracture 276 (1.08) 3629 (39.17) 3078 (13.78) 6983 (12.22)
others 539 (2.11) 810 (8.74) 1594 (7.14) 2943 (5.15)
Overall 25,554 (44.71) 9265 (16.21) 22,337 (39.08) 57,156 (100)

3.3. Trend of different procedures

From 2011 to 2013, TSA was the most performed procedure compared to RSA and HA with a steady percentage of 45 (Fig. 2A). The percentage of TSA experienced a decline in 2014 (43%) and was overtaken by RSA (46%) for the most performed surgery, which had been increasing steadily since 2011. On the other hand, the percentage of HA was the lowest in 2011 and has been gradually decreasing since 2011.

Figure 2.

Figure 2.

Trends of primary shoulder arthroplasties 2011–2014. (A) All procedures combined. (B) Procedures for patients diagnosed with OA. (C) Patients with OA and rotator cuff deficiency. (D) Patients with OA but not rotator cuff deficiency.

When examining specifically for patients with OA who underwent surgery, the most performed surgery was TSA at 60% with a slight decline started in 2013 (Fig. 2B). RSA was the second most performed surgery started at 22.5% and increased to 32.8% in 2014. HA was the least performed and has been steadily decreasing since 2011 to 6%.

A breakdown of procedures for patients with OA and rotator cuff deficiency was examined. RSA was the most performed procedure started at 55% and gradually increased to 70% (Fig. 2C). The second most performed surgery was TSA, started at 32% and progressively decreased to 25%. HA was the least performed, started at 11% and decreased to 5%.

For OA patients but without rotator cuff deficiency (Fig. 2D), TSA was the most performed started at 70%, which slightly increased then fell back to 72%. HA experienced a steady decline and was overtaken by RSA in 2012. RSA increased from 15 to 19% and HA decreased to 8% in 2014.

3.4. Postoperative complications

Postoperative outcomes were compared between TSA and RSA, the main subjects of interest. Only patients with OA were analyzed. To minimize confounding factors and reduce sample variability, patients were matched by age, sex, race, geographic location, and comorbidities. Unmatched and matched patient demographic data can be found in Supplementary Table 2, http://links.lww.com/MD/H62 and Supplementary Table 3, http://links.lww.com/MD/H62, respectively.

OA patients were grouped by the presence of rotator cuff deficiency. In the rotator cuff deficiency group (Table 3, left side), significant higher number of transfusions was found for RSA patients (70 vs 97, P = .0399). Length of hospital stay was significantly higher for RSA patients (1.93 vs 2.01days, P = .0021). In OA patients without rotator cuff deficiency (Table 3, right side), statistical significant was found for the number of implant-related mechanical complication (8 vs 29, P = .0007), acute upper respiratory infections (0 vs 6, P = .0312), acute postoperative pain (85 vs 130, P = .0023). Length of hospital stay was higher in RSA patients (2.08 vs 2.25 days, P < .0001). Regarding total cost of surgery, TSA had lower costs compared to RSA in both groups (P < .0001 in both groups).

Table 3.

Complications, length of stay, and cost of osteoarthritis patients with or without rotator cuff deficiencies undergo TSA or RSA.

Variables With rotator cuff deficiency Without rotator cuff deficiency
TSA RSA P value OR (95% CI) TSA RSA P value OR (95% CI)
Mechanical complication of implant 6 (0.27) 4 (0.18) 0.7536 0.67 (0.19–2.36) 8 (0.17) 29 (0.63) 0.0007 3.64 (1.66–7.97)
Nervous system complications 1 (0.05) 1 (0.05) 1 1 (0.06–16) 5 (0.11) 5 (0.11) 1 1 (0.29–3.46)
Cardiac complications 10 (0.45) 9 (0.41) 1 0.9 (0.36–2.22) 18 (0.39) 25 (0.54) 0.3593 1.39 (0.76–2.55)
Peripheral vascular complications 2 (0.09) 1 (0.05) 1 0.5 (0.05–5.52) 1 (0.02) 3 (0.06) 0.6249 3 (0.31–28.86)
Respiratory complications 7 (0.32) 6 (0.27) 1 0.86 (0.29–2.55) 23 (0.5) 11 (0.24) 0.0572 0.48 (0.23–0.98)
Digestive system complications 3 (0.14) 3 (0.14) 1 1 (0.2–4.96) 15 (0.32) 7 (0.15) 0.1333 0.47 (0.19–1.14)
Urinary complications 6 (0.27) 11 (0.5) 0.3314 1.84 (0.68–4.98) 29 (0.63) 29 (0.63) 1 1 (0.6–1.68)
Postoperative shock 0 (0) 2 (0.09) 0.4999 0 (0) 4 (0.09) 0.1249
Hemorrhage or hematoma 4 (0.18) 6 (0.27) 0.7536 1.5 (0.42–5.33) 12 (0.26) 17 (0.37) 0.4575 1.42 (0.68–2.97)
Postoperative infection 1 (0.05) 1 (0.05) 1 1 (0.06–16) 2 (0.04) 1 (0.02) 1 0.5 (0.05–5.51)
Urinary tract infection 25 (1.14) 27 (1.23) 0.8892 1.08 (0.63–1.87) 79 (1.71) 101 (2.18) 0.1137 1.28 (0.95–1.73)
Acute upper respiratory infections 2 (0.09) 0 (0) 0.4999 0 (0.01–5.54) 0 (0) 6 (0.13) 0.0312
Acute postoperative pain 68 (3.09) 67 (3.05) 1 0.98 (0.7–1.39) 85 (1.84) 130 (2.81) 0.0023 1.54 (1.17–2.04)
Chronic postoperative pain 1 (0.05) 0 (0) 1 0 (0.02–14.9) 1 (0.02) 0 (0) 1 0 (0.02–14.9)
Transfusion 70 (3.18) 97 (4.41) 0.0399 1.4 (1.03–1.92) 182 (3.93) 306 (6.61) <0.0001 1.73 (1.43–2.09)
Length of stay
 Mean (SD) 1.93 (1.12) 2.01 (1.07) 0.0021 RSA-TSA
0.08
2.08 (1.33) 2.25 (1.52) <0.0001 RSA-TSA
0.17
 Median 2 2 2 2
Cost
 Mean (SD) 16960.36 (6915.39) 19468.65 (7723.6) <0.0001 RSA-TSA
2508.29
16860.74 (6800.91) 19816.6 (8362.91) <0.0001 RSA-TSA
2955.86
 Median 15694.5 18018.86 15,536 18212.88

4. Discussion

In this study, we queried the NIS database to investigate surgical outcomes of TSA and RSA for OA patients with and without rotator cuff deficiency. RSA was originally designed for repair of rotator cuff injury and shoulder pseudoparalysis,[13,26,27] therefore, we wanted to evaluate if the use of RSA in place of the clinically standard TSA was justified for OA patients without rotator cuff deficiency.

Initially we had gathered data on HA, the focus was gradually shifted to focus on comparing TSA to RSA as HA has fallen out of favor over the years for the management of OA.

According to our data (Fig. 2) and also results from previous studies, RSA has a trend of increasing popularity each year.[20,28] It has even surpassed TSA and became the most performed shoulder arthroplasty procedure in 2014 (Fig. 2A) due to its expanded indications for other shoulder arthropathies.[2936]

Although TSA remains the most frequently performed arthroplasty for OA patients, RSA increased over 10% (Fig. 2B) since 2011 from 22.5 to 32.8%. Upon further analysis of this data, in OA patients with rotator cuff deficiency (Fig. 2C), there was a dramatic increase of RSA performed (55–70%), while TSA experienced a decline from 32 to 25%. In OA patients without rotator cuff deficiency (Fig. 2D), TSA remained high with a slight decline in 2014 (72%), while RSA had a gradual increase (15 to 19%), although not as dramatic as in patients with rotator cuff deficiency. Among all OA patients who underwent RSA, only 54.17% (5469 out of 10,096, Supplementary Table 2, http://links.lww.com/MD/H62) of the study patients had rotator cuff or bursa deficiencies. For these patients, complication profiles are very similar between TSA and RSA (Table 3), only the rate of blood transfusion in RSA patients was higher than TSA patients. Although the length of hospital stay and surgical cost are significantly higher than TSA patients, RSA is still a good option considering the surgical benefits of RSA for patients with rotator cuff deficiency. RSA restores balance to the shoulder as it is designed to restore tension to the deltoid and keeps the center of joint rotation within the glenoid fossa,[37,38] which is necessary when the rotator cuff is insufficient.[3941]

On the other hand, there were as high as 45.83% (4627 out of 10,096, Supplementary Table 2, http://links.lww.com/MD/H62) of OA patients without rotator cuff that received RSA. For these patients, the benefit of RSA was limited. Furthermore, there were greater incidence of postoperative complications in patients who received RSA. The number of patients who had mechanical complication (8 vs 29), acute upper respiratory infection (6 vs 0, RSA vs TSA), acute pain (130 vs 85, RSA vs TSA), and blood transfusions (306 vs 182, RSA vs TSA) are significantly higher. Besides, after RSA, the stability and mobility of the glenohumeral joint become dependent on the deltoid.[42] As a result, there is a higher requirement for postoperative physiotherapy,[43,44] which results in higher costs. Moreover, given the higher rate of multiple complications, and especially when the surgical cost of RSA and length of hospital stay are significantly higher, the use of RSA instead of TSA in patients without rotator cuff deficiencies may not be justified.

Although the indications for RSA have been expanded in the last few years,[35,45] RSA is still being applied outside of the indicated conditions. However, once RSA has been done, future revision will be very difficult due to severely altered anatomy.[4648] Furthermore, considering the high rate of complication and cost, surgeons should carefully reconsider the use of RSA outside of its indications.

There are some limitations in this study. First, the data was collected from the online database, many details were not applicable, this makes it difficult to in-depth analyze. Second, this study only analyzed data between 2011 and 2014, the data after 2014 was not included, an updated analysis will renew our Acknowledgments.

5. Conclusions

With the help National Inpatient Sample database, more impactful studies involving larger number of patients can be conducted to better understand and compare surgical outcomes between procedures. We found that the use of RSA in the management of OA patients without rotator cuff deficiency had significantly more complications compared to those managed with TSA. Surgeons may need to reconsider when attempting to perform RSA in these patients. Future studies may need to focus on identifying factors causing higher risk of postoperative complications for RSA compared to TSA in this patient population to further improve the safety of shoulder arthroplasties.

Author contributions

Haifeng Liu, Daping Wang, and Zeling Long conceived the project idea. Haifeng Liu, Zeling Long, and Hanzhong Yu designed the project, collected data, and performed data analysis. Haifeng Liu, Zeling Long, Tony Chieh-Ting Huang, and Hanzhong Yu wrote the manuscript. Daping Wang, Yicun Wang supported and supervised the findings of this work. All authors contributed to the final manuscript. All authors have read and approved the final submitted manuscript.

Supplementary Material

medi-101-e29896-s001.pdf (100.1KB, pdf)

Abbreviations:

HA =
hemiarthroplasty
ICD-9-CM =
International Classification of Diseases-9th Revision-Clinical Modification
NIS =
Nationwide Inpatient Sample
OA =
osteoarthritis
RSA =
reverse total shoulder arthroplasty
TSA =
total shoulder arthroplasty

Supplemental Digital Content is available for this article.

The authors have no competing interests.

Funding: Zeling Long was funded by the China scholarship council.

Ethical approval: The study protocol has been approved by ShenZhen University Ethics Committee.

Informed consent: The study examined regional cost differences for congestive heart failure admissions using discharge data from the National Inpatient Sample and the Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. All subjects included signed an informed consent.

The datasets generated during and/or analyzed during the current study are publicly available. The National (Nationwide) Inpatient Sample (NIS) is the largest publicly available all-payer inpatient care database in the United States, containing data on more than 7 million hospital stays. All data used in this study is available online.

How to cite this article: Liu H, Huang TC-T, Yu H, Wang Y, Wang D, Long Z. Total shoulder arthroplasty versus reverse total shoulder arthroplasty: outcome comparison in osteoarthritis patients with or without concurrent rotator cuff deficiency. Medicine 2022;101:32(e29896).

P value was calculated by chi-squared test for categorical variables and 1-way ANOVA test for numerical variables. HA = hemiarthroplasty; RSA = reverse total shoulder arthroplasty; TSA = total shoulder arthroplasty.

TSA = total shoulder arthroplasty, HA = hemiarthroplasty, RSA = reverse total shoulder arthroplasty.

P value was calculated by Chi-squared test or Fisher exact test for categorical variables, and t-test or Wilcoxon rank-sum test for numerical variables.

CI = confidence interval, OR = odds ratio, RSA = reverse total shoulder arthroplasty, SD = standard deviation, TSA = total shoulder arthroplasty.

References

  • [1].Chillemi C, Franceschini V. Shoulder osteoarthritis. Arthritis. 2013;2013:370231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Izquierdo R, Voloshin I, Edwards S, et al. Treatment of glenohumeral osteoarthritis. J Am Acad Orthop Surg. 2010;18:375–82. [DOI] [PubMed] [Google Scholar]
  • [3].Boorman RS, Kopjar B, Fehringer E, et al. The effect of total shoulder arthroplasty on self-assessed health status is comparable to that of total hip arthroplasty and coronary artery bypass grafting. J Shoulder Elbow Surg. 2003;12:158–63. [DOI] [PubMed] [Google Scholar]
  • [4].Fehringer EV, Kopjar B, Boorman RS, et al. Characterizing the functional improvement after total shoulder arthroplasty for osteoarthritis. J Bone Joint Surg Am. 2002;84:1349–53. [DOI] [PubMed] [Google Scholar]
  • [5].Gartsman GM, Roddey TS, Hammerman SM. Shoulder arthroplasty with or without resurfacing of the glenoid in patients who have osteoarthritis. J Bone Joint Surg Am. 2000;82:26–34. [DOI] [PubMed] [Google Scholar]
  • [6].Iannotti JP, Norris TR. Influence of preoperative factors on outcome of shoulder arthroplasty for glenohumeral osteoarthritis. J Bone Joint Surg Am. 2003;85:251–8. [DOI] [PubMed] [Google Scholar]
  • [7].Orfaly RM, Rockwood CA, Jr., Esenyel CZ, et al. A prospective functional outcome study of shoulder arthroplasty for osteoarthritis with an intact rotator cuff. J Shoulder Elbow Surg. 2003;12:214–21. [DOI] [PubMed] [Google Scholar]
  • [8].Raiss P, Aldinger PR, Kasten P, et al. Total shoulder replacement in young and middle-aged patients with glenohumeral osteoarthritis. J Bone Joint Surg Br. 2008;90-B:764–9. [DOI] [PubMed] [Google Scholar]
  • [9].Wirth MA, Tapscott RS, Southworth C, et al. Treatment of glenohumeral arthritis with a hemiarthroplasty: a minimum five-year follow-up outcome study. J Bone Joint Surg Am. 2006;88:964–73. [DOI] [PubMed] [Google Scholar]
  • [10].Norris TR, Iannotti JP. Functional outcome after shoulder arthroplasty for primary osteoarthritis: a multicenter study. J Shoulder Elbow Surg. 2002;11:130–5. [DOI] [PubMed] [Google Scholar]
  • [11].Worland RL, Arredondo J. Bipolar shoulder arthroplasty for painful conditions of the shoulder. J Arthroplasty. 1998;13:631–7. [DOI] [PubMed] [Google Scholar]
  • [12].Lo IK, Litchfield RB, Griffin S, et al. Quality-of-life outcome following hemiarthroplasty or total shoulder arthroplasty in patients with osteoarthritis. A prospective, randomized trial. J Bone Joint Surg Am. 2005;87:2178–85. [DOI] [PubMed] [Google Scholar]
  • [13].Boileau P, Watkinson DJ, Hatzidakis AM, et al. Grammont reverse prosthesis: design, rationale, and biomechanics. J Shoulder Elbow Surg. 2005;14(1 Suppl S):147s–61s. [DOI] [PubMed] [Google Scholar]
  • [14].Randelli P, Randelli F, Compagnoni R, et al. Revision reverse shoulder arthroplasty in failed shoulder arthroplasties for rotator cuff deficiency. Joints. 2015;3:31–7. [PMC free article] [PubMed] [Google Scholar]
  • [15].Boileau P, Gonzalez J-F, Chuinard C, et al. Reverse total shoulder arthroplasty after failed rotator cuff surgery. J Shoulder Elbow Surg. 2009;18:600–6. [DOI] [PubMed] [Google Scholar]
  • [16].Levy J, Virani N, Pupello D, et al. Use of the reverse shoulder prosthesis for the treatment of failed hemiarthroplasty in patients with glenohumeral arthritis and rotator cuff deficiency. J Bone Joint Surg Br. 2007;89:189–95. [DOI] [PubMed] [Google Scholar]
  • [17].Boileau P, Watkinson D, Hatzidakis AM, et al. Neer Award 2005: the Grammont reverse shoulder prosthesis: results in cuff tear arthritis, fracture sequelae, and revision arthroplasty. J Shoulder Elbow Surg. 2006;15:527–40. [DOI] [PubMed] [Google Scholar]
  • [18].Ramirez MA, Ramirez J, Murthi AM. Reverse total shoulder arthroplasty for irreparable rotator cuff tears and cuff tear arthropathy. Clin Sports Med. 2012;31:749–59. [DOI] [PubMed] [Google Scholar]
  • [19].Jobin CM, Brown GD, Bahu MJ, et al. Reverse total shoulder arthroplasty for cuff tear arthropathy: the clinical effect of deltoid lengthening and center of rotation medialization. J Shoulder Elbow Surg. 2012;21:1269–77. [DOI] [PubMed] [Google Scholar]
  • [20].Palsis JA, Simpson KN, Matthews JH, et al. Current trends in the use of shoulder arthroplasty in the United States. Orthopedics. 2018;41:e416–23. [DOI] [PubMed] [Google Scholar]
  • [21].Barco R, Savvidou OD, Sperling JW, et al. Complications in reverse shoulder arthroplasty. EFORT Open Rev. 2017;1:72–80. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Chalmers BP, Wagner ER, Sperling JW, et al. Treatment and outcomes of reverse shoulder arthroplasty dislocations. J Shoulder Elbow Arthroplasty. 2017;1:2471549217695262471549217695260. [Google Scholar]
  • [23].Villacis D, Sivasundaram L, Pannell WC, et al. Complication rate and implant survival for reverse shoulder arthroplasty versus total shoulder arthroplasty: results during the initial 2 years. J Shoulder Elbow Surg. 2016;25:927–35. [DOI] [PubMed] [Google Scholar]
  • [24].Groh GI, Groh GM. Complications rates, reoperation rates, and the learning curve in reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23:388–94. [DOI] [PubMed] [Google Scholar]
  • [25].Nam D, Kepler CK, Neviaser AS, et al. Reverse total shoulder arthroplasty: current concepts, results, and component wear analysis. J Bone Joint Surg Am. 2010;92(Suppl 2):23–35. [DOI] [PubMed] [Google Scholar]
  • [26].Baulot E, Sirveaux F, Boileau P. Grammont’s idea: the story of Paul Grammont’s functional surgery concept and the development of the reverse principle. Clin Orthop Relat Res. 2011;469:2425–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Gerber C, Pennington SD, Nyffeler RW. Reverse total shoulder arthroplasty. J Am Acad Orthop Surg. 2009;17:284–95. [DOI] [PubMed] [Google Scholar]
  • [28].Wright MA, Keener JD, Chamberlain AM. Comparison of clinical outcomes after anatomic total shoulder arthroplasty and reverse shoulder arthroplasty in patients 70 years and older with glenohumeral osteoarthritis and an intact rotator cuff. J Am Acad Orthop Surg. 2020;28:e222–e29. [DOI] [PubMed] [Google Scholar]
  • [29].Boileau P, Trojani C, Walch G, et al. Shoulder arthroplasty for the treatment of the sequelae of fractures of the proximal humerus. J Shoulder Elbow Surg. 2001;10:299–308. [DOI] [PubMed] [Google Scholar]
  • [30].Chalmers PN, W SI, Mall NA, et al. Reverse total shoulder arthroplasty for acute proximal humeral fracture: comparison to open reduction–internal fixation and hemiarthroplasty. J Shoulder Elbow Surg. 2014;23:197–204. [DOI] [PubMed] [Google Scholar]
  • [31].Gallinet D, Adam A, Gasse N, et al. Improvement in shoulder rotation in complex shoulder fractures treated by reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22:38–44. [DOI] [PubMed] [Google Scholar]
  • [32].Young AA, Smith MM, Bacle G, et al. Early results of reverse shoulder arthroplasty in patients with rheumatoid arthritis. J Bone Joint Surg Am. 2011;93:1915–23. [DOI] [PubMed] [Google Scholar]
  • [33].Patel DN, Young B, Onyekwelu I, et al. Reverse total shoulder arthroplasty for failed shoulder arthroplasty. J Shoulder Elbow Surg. 2012;21:1478–83. [DOI] [PubMed] [Google Scholar]
  • [34].De Wilde L, Boileau P, Van der Bracht H. Does reverse shoulder arthroplasty for tumors of the proximal humerus reduce impairment? Clin Orthop Relat Res. 2011;469:2489–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Drake GN, O’Connor DP, Edwards TB. Indications for reverse total shoulder arthroplasty in rotator cuff disease. Clin Orthop Relat Res. 2010;468:1526–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Mizuno N, Denard PJ, Raiss P, et al. Reverse total shoulder arthroplasty for primary glenohumeral osteoarthritis in patients with a biconcave glenoid. J Bone Joint Surg Am. 2013;95:1297–304. [DOI] [PubMed] [Google Scholar]
  • [37].Grammont P, Baulot E. Delta shoulder prosthesis for rotator cuff rupture. Orthopedics. 1993;16:65–8. [DOI] [PubMed] [Google Scholar]
  • [38].Grammont P, Trouilloud P, Laffay J, et al. Study and development of a new shoulder prosthesis [in French]. Rhumatologie. 1987;39:407–18. [Google Scholar]
  • [39].Bezer M, Yildirim Y, Akgün U, et al. Superior excursion of the humeral head: a diagnostic tool in rotator cuff tear surgery. J Shoulder Elbow Surg. 2005;14:375–9. [DOI] [PubMed] [Google Scholar]
  • [40].Keener JD, Wei AS, Kim HM, et al. Proximal humeral migration in shoulders with symptomatic and asymptomatic rotator cuff tears. J Bone Joint Surg Am. 2009;91:1405–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Su W-R, Budoff JE, Luo Z-P. The effect of anterosuperior rotator cuff tears on glenohumeral translation. Arthroscopy. 2009;25:282–89. [DOI] [PubMed] [Google Scholar]
  • [42].Langohr GDG, Willing R, Medley JB, et al. Contact mechanics of reverse total shoulder arthroplasty during abduction: the effect of neck-shaft angle, humeral cup depth, and glenosphere diameter. J Shoulder Elbow Surg. 2016;25:589–97. [DOI] [PubMed] [Google Scholar]
  • [43].Buchmann S, Schoch C, Grim C, et al. Rehabilitation following reverse shoulder arthroplasty. Obere Extremität. 2019;14:269–83. [Google Scholar]
  • [44].Wilcox RB, Arslanian LE, Millett PJ. Rehabilitation following total shoulder arthroplasty. J Orthop Sports Phys Ther. 2005;35:821–36. [DOI] [PubMed] [Google Scholar]
  • [45].Wiater MJ, Fabing MH. Shoulder arthroplasty: prosthetic options and indications. J Am Acad Orthop Surg. 2009;17:415–25. [DOI] [PubMed] [Google Scholar]
  • [46].Boileau P, Melis B, Duperron D, et al. Revision surgery of reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2013;22:1359–70. [DOI] [PubMed] [Google Scholar]
  • [47].Holcomb JO, Cuff D, Petersen SA, et al. Revision reverse shoulder arthroplasty for glenoid baseplate failure after primary reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2009;18:717–23. [DOI] [PubMed] [Google Scholar]
  • [48].Zumstein MA, Pinedo M, Old J, et al. Problems, complications, reoperations, and revisions in reverse total shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg. 2011;20:146–57. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

medi-101-e29896-s001.pdf (100.1KB, pdf)

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES